Nanoform Finland Oyj Company Description

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.

The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances.

It also offers STARMAP, an online platform to pick winners among candidate molecules for CESS powered nanoforming.

The company was founded in 2008 and is headquartered in Helsinki, Finland.

Nanoform Finland Oyj

Country	Finland
Founded	2008
Industry	Biotechnology
Sector	Healthcare
Employees	181
CEO	Edward Haeggstrom

Contact Details

Address: Cultivator II Helsinki, 00790 Finland
Phone	358 2937 00150
Website	nanoform.com

Stock Details

Ticker Symbol	NANOFS
Exchange	Nasdaq Stockholm
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	FI4000330972
SIC Code	8731

Key Executives

Name	Position
Prof. Edward Olof Haeggstrom	Co-Founder and Chief Executive Officer
Albert Alexander Haeggstrom	Chief Financial Officer and Director
Henri von Haartman	Director of Investor Relations
Peter Hanninen	General Counsel and Chief Development Officer
Dr. David Rowe	Head of Manufacturing
Christian Jones	Chief Commercial Officer
Antonio Da Silva	Chief of Business Operations
Johanna Kause	Chief Quality Officer
Dr. Jamie Unwin	Vice President of Strategic Insight